Star Imaging and Path Lab Ltd

Star Imaging and Path Lab Ltd

None%
- close price
About

Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.[1]

Key Points

Business Profile[1]
Star Imaging and Path Lab Limited (originally Janta X-Ray Clinic) is a Delhi-based diagnostic healthcare service provider offering pathology, radiology, cardiology, and neurology services. The company operates through B2C, B2B, and B2G models, with NABL-accredited facilities.

  • Market Cap 247 Cr.
  • Current Price
  • High / Low /
  • Stock P/E 15.5
  • Book Value
  • Dividend Yield %
  • ROCE 34.7 %
  • ROE 40.6 %
  • Face Value 10.0

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.9%

Cons

  • Company has high debtors of 222 days.
  • Working capital days have increased from 43.5 days to 121 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
69 58 79 84
54 52 55 54
Operating Profit 15 6 23 29
OPM % 21% 10% 30% 35%
0 0 1 0
Interest 2 2 3 3
Depreciation 4 3 5 5
Profit before tax 9 1 16 21
Tax % 33% 35% 23% 26%
6 1 12 16
EPS in Rs
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 7%
TTM: 6%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 36%
TTM: 37%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 34%
Last Year: 41%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 2 2 2 14
Reserves 17 17 30 34
30 27 31 33
10 16 20 18
Total Liabilities 58 61 82 98
15 19 22 21
CWIP 0 0 0 0
Investments 0 0 0 0
43 42 60 77
Total Assets 58 61 82 98

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
14 5 18 -6
-4 -7 -7 -4
-7 -5 2 -0
Net Cash Flow 3 -7 13 -10

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 85 110 152 222
Inventory Days
Days Payable
Cash Conversion Cycle 85 110 152 222
Working Capital Days 6 -13 23 121
ROCE % 6% 34% 35%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports

No data available.